SPRINGFIELD – A measure from Sen. Melinda Bush, D-Grayslake, to reduce opioid abuse and “doctor shopping” advanced out of both legislative chambers with unanimous support.
Senate Bill 772 would require prescribers of controlled substances to check the Prescription Monitoring Program database to see if a patient has been prescribed a controlled substance by another doctor prior to writing an initial prescription. This would make it harder for individuals to obtain prescriptions from multiple doctors, a practice known as doctor shopping.
“Drug overdose is the leading cause of accidental death in the United States,” Bush said. “The prescription monitoring program can help curb opioid addiction and overdose by reducing the problem of overprescribing, but it will only be successful if prescribers actually check the database before writing a script.”
In 2015, Bush sponsored the legislation that required pharmacies to file daily reports of all controlled substances they dispense. Under the current law, however, prescribers of controlled substances are not required to check the Prescription Monitoring Program database before writing prescriptions. Studies show that as few as 14 percent of physicians always check the database before prescribing controlled substances.
“Checking the prescription monitoring program database before writing a prescription is easy for doctors and an essential step in combatting the opioid epidemic in Illinois,” Bush said. “This measure will help curb doctor shopping, prevent overdoses and save countless lives.”